arrow
J

Jaime Ramos

Universidad de Cádiz
H指数:13
被引数:469

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Assessing COVID-19 Vaccine Effectiveness and Risk Factors for Severe Outcomes through Machine Learning Techniques: A Real-World Data Study in Andalusia, Spain
2024-11-111
PRE
Transmural remission improves clinical outcomes up to 5 years in Crohn's disease
2022-12-2713
OAAI
Adverse events reported after administration of BNT162b2 and mRNA-1273 COVID-19 vaccines among hospital workers: a cross-sectional survey-based study in a Spanish hospital

在医院工作人员中使用BNT162b2和mRNA-1273新型冠状病毒肺炎疫苗后报告的不良事件: 西班牙一家医院的横断面调查研究

2022-01-0510
OA
Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab
2019-08-305
OAAI
Low Golimumab Trough Levels at Week 6 Are Associated With Poor Clinical, Endoscopic and Histological Outcomes in Ulcerative Colitis Patients: Pharmacokinetic and Pharmacodynamic Sub-analysis of the Evolution Study
2019-04-1614
OAAI
Correlation between soluble suppression of tumorigenicity 2 (sST2) and endoscopic activity in patients with moderate to severe ulcerative colitis under golimumab treatment: results of the EVOLUTION study
2019-01-250
OAAI
Clinical performance of an infliximab rapid quantification assay
2017-08-1118
OAAI
Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation
2017-07-018
OAAI
Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assays
2016-07-2816
OAAI